These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35460473)

  • 1. Outcomes of Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Valvular Heart Disease.
    Dawwas GK; Barnes GD
    Curr Cardiol Rep; 2022 Jun; 24(6):731-738. PubMed ID: 35460473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: A Systematic Review and Meta-Analysis.
    Pan KL; Singer DE; Ovbiagele B; Wu YL; Ahmed MA; Lee M
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28720644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct oral anticoagulant use in nonvalvular atrial fibrillation with valvular heart disease: a systematic review.
    Owens RE; Kabra R; Oliphant CS
    Clin Cardiol; 2017 Jun; 40(6):407-412. PubMed ID: 28004413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial.
    De Caterina R; Renda G; Carnicelli AP; Nordio F; Trevisan M; Mercuri MF; Ruff CT; Antman EM; Braunwald E; Giugliano RP
    J Am Coll Cardiol; 2017 Mar; 69(11):1372-1382. PubMed ID: 28302288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Efficacy of Novel Oral Anticoagulants Versus Warfarin in Medicare Beneficiaries With Atrial Fibrillation and Valvular Heart Disease.
    Briasoulis A; Inampudi C; Akintoye E; Alvarez P; Panaich S; Vaughan-Sarrazin M
    J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29622591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can Direct Oral Anticoagulants Be Used for Stroke Prevention Among Patients with Valvular Atrial Fibrillation?
    Anderson SL; Marrs JC
    Curr Cardiol Rep; 2019 Aug; 21(10):118. PubMed ID: 31473836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel oral anticoagulants and valvular atrial fibrillation: are they always contraindicated?
    Di Pasquale G; Zagnoni S; Riva L
    Intern Emerg Med; 2015 Feb; 10(1):21-4. PubMed ID: 25589164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the New Oral Anticoagulants and Warfarin in Patients with Atrial Fibrillation and Valvular Heart Disease: Systematic Review and Meta-Analysis.
    de Souza Lima Bitar Y; Neto MG; Filho JAL; Pereira LV; Travassos KSO; Akrami KM; Roever L; Duraes AR
    Drugs R D; 2019 Jun; 19(2):117-126. PubMed ID: 31055767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Valvular Atrial Fibrillation : A Population-Based Cohort Study.
    Dawwas GK; Dietrich E; Cuker A; Barnes GD; Leonard CE; Lewis JD
    Ann Intern Med; 2021 Jul; 174(7):910-919. PubMed ID: 33780291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Bioprosthetic Heart Valves.
    Duan L; Doctor JN; Adams JL; Romley JA; Nguyen LA; An J; Lee MS
    Am J Cardiol; 2021 May; 146():22-28. PubMed ID: 33529622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
    Lip GYH; Collet JP; Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B;
    Europace; 2017 Nov; 19(11):1757-1758. PubMed ID: 29096024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboembolism and Major Bleeding in Patients with Atrial Fibrillation and EHRA Type 2 Valvular Heart Disease: The Jordan Atrial Fibrillation (JoFib) Study.
    Al-Najar M; Al-Nusair M; Alrabadi N; Alawaisheh I; Alawaisheh T; Jarrah M; Alzoubi KH; Njem S; Hamoudeh A
    Vasc Health Risk Manag; 2023; 19():145-155. PubMed ID: 36968249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.
    Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC
    Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease.
    Renda G; Ricci F; Giugliano RP; De Caterina R
    J Am Coll Cardiol; 2017 Mar; 69(11):1363-1371. PubMed ID: 28302287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct-acting oral anticoagulants in patients with atrial fibrillation and valvular heart disease.
    Canales N; Cao T; Fakourfar N; Snee M; Tsu L
    JAAPA; 2022 Sep; 35(9):17-18. PubMed ID: 36007114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis.
    See LC; Lee HF; Chao TF; Li PR; Liu JR; Wu LS; Chang SH; Yeh YH; Kuo CT; Chan YH; Lip GYH
    Cardiovasc Drugs Ther; 2021 Oct; 35(5):975-986. PubMed ID: 33211254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subtypes of atrial fibrillation with concomitant valvular heart disease derived from electronic health records: phenotypes, population prevalence, trends and prognosis.
    Banerjee A; Allan V; Denaxas S; Shah A; Kotecha D; Lambiase PD; Joseph J; Lund LH; Hemingway H
    Europace; 2019 Dec; 21(12):1776-1784. PubMed ID: 31408153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct oral anticoagulants compared with other strategies in patients with atrial fibrillation and stroke or transient ischemic attack: Systematic review.
    Lee KH; Hung WT; Huang WY; Ovbiagele B; Lee M
    J Formos Med Assoc; 2024 May; 123(5):551-560. PubMed ID: 37838540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes in anticoagulated patients with atrial fibrillation and with mitral or aortic valve disease.
    Vinereanu D; Wang A; Mulder H; Lopes RD; Jansky P; Lewis BS; Gersh BJ; Avezum A; Hanna M; Held C; Wallentin L; Granger CB; Alexander JH
    Heart; 2018 Aug; 104(15):1292-1299. PubMed ID: 29352007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex.
    Carnicelli AP; Hong H; Connolly SJ; Eikelboom J; Giugliano RP; Morrow DA; Patel MR; Wallentin L; Alexander JH; Cecilia Bahit M; Benz AP; Bohula EA; Chao TF; Dyal L; Ezekowitz M; A A Fox K; Gencer B; Halperin JL; Hijazi Z; Hohnloser SH; Hua K; Hylek E; Toda Kato E; Kuder J; Lopes RD; Mahaffey KW; Oldgren J; Piccini JP; Ruff CT; Steffel J; Wojdyla D; Granger CB;
    Circulation; 2022 Jan; 145(4):242-255. PubMed ID: 34985309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.